Research Study

A Two-year, Three-arm, Randomized, Double-masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to Diabetic Macular Edema
Principal Investigator 
Patrick Ma

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT03481634
Status 
Recruiting
Study Start/End 
Sep 25, 2018 to Sep 30, 2020
Locations 
Vancouver General Hospital
Name/Title 
Theresa Wiens, Clinical Research Manager
Phone 
604-875-4111 ext.62544
Purpose of Study 

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of patients with visual impairment due to diabetic macular edema (DME).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.